OpenLegislation

The Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2015

S.R. 2015/53 · Made 12 February 2015

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Dangerous Drugs

Made 12th February 2015

Coming into operation 5th March 2015

The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971f1 as adapted by sections 7(9), 31(4) and 38 of that Act and now vested in itf2 and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act.

Annotations to the whole text

Footnotes

f1

1971 c.38 as amended by s.151 of, and Schedule 17 to, the Police Reform and Social Responsibility Act 2011 c.13.

f2

S.R.& O. (N.I.) 1973 No.504, Article 5(a) and S.I.1999/283 (N.I.1), Article 3(6).

Contents

  1. 1Citation, commencement and interpretation
  2. 2Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  3. 3Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  4. 4Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  5. 5Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  6. 6Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
  7. Signature
  8. Explanatory note

1Citation, commencement and interpretation

(1)

These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2015 and come into operation on 5th March 2015.

(2)

The Interpretation Act (Northern Ireland) 1954f1 shall apply to these Regulations as it applies to an Act of the Northern Ireland Assembly.

2Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

The Misuse of Drugs Regulations (Northern Ireland) 2002f1 are amended as follows

3Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of Regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27)—

(a)

after “Tenocyclidine” insert—

“(6aR,9R-4-acetyl-N, N-diethyl-7-methyl-4, 6, 6a, 7, 8, 9-hexahydroindolo[4, 3-fg]quinoline-9-carboxamide (ALD-52”;

(b)

after “4-Bromo-2,5-dimethoxy-a-methylphenethylamine” insert—

“3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)

(6aR,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD)

(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD)

(6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD)”

(c)

after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert—

“2,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3- fg]quinolin-9-yl}methanone (LSZ)”.

4Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

For paragraph 1(b) of Schedule 1, substitute—

“(b)

any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say—

(i)

by substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;

(ii)

by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;

(iii)

by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;

(iv)

by substitution at the 2-position of the tryptamine ring system with an alkyl substituent”.

5Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

In paragraph 1 of Schedule 2 (which specifies controlled drugs subject to the requirements of Regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27) after “Hydromorphone” insert—

“4-Hydroxy-n-butyric acid”.

6Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

In paragraph 1 of Part 1 of Schedule 4 (controlled drugs subject to the requirements of Regulations 22, 23, 26 and 27) omit “4-Hydroxy-n-butyric acid”f1.

Signature

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 12th February 2015

L.S.

Dr Paddy Woods

A senior officer of the

Department of Health, Social Services and Public Safety

Explanatory note

(This note is not part of the Regulations)

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002. The Schedule of the Regulations in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the Regulations are those subject to the tightest controls.

Regulation 3 adds certain LSD related compounds and the synthetic opiate known as AH-7921 to Schedule 1 of the Regulations. Regulation 4 replaces the definition of tryptamine compounds in Schedule 1 with a wider generic definition. Regulations 5 and 6 move 4-Hydroxy-n-butyric acid (‘GHB’) from Part 1 of Schedule 4 of the Regulations to Schedule 2.